GALEXI Trademark

Trademark Overview


On Friday, June 11, 2021, a trademark application was filed for GALEXI with the United States Patent and Trademark Office. The USPTO has given the GALEXI trademark a serial number of 79315195. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Agilex Biolabs Pty Ltd. The GALEXI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Advisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to pharmaceutical product testing; advisory services relating to science in the field of bioanalytics; advisory services relating to scientific research in the field of bioanalytics; analysis of materials, namely, bioanalytical services; analytical scientific laboratory services in the field of bioanalytics; biochemistry research services; biochemistry services; biological research; biotechnological research; biotechnology research; biotechnology testing; development of computer systems for the processing of data in the field of bioanalytics; development of chemical production testing methods for medical clinical trials; scientific research in the nature of conducting medical clinical trials for others; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research in the field of bioanalytics; medical research laboratory serv...
galexi

General Information


Serial Number79315195
Word MarkGALEXI
Filing DateFriday, June 11, 2021
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6881898
Registration DateTuesday, October 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements


Goods and ServicesAdvisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to pharmaceutical product testing; advisory services relating to science in the field of bioanalytics; advisory services relating to scientific research in the field of bioanalytics; analysis of materials, namely, bioanalytical services; analytical scientific laboratory services in the field of bioanalytics; biochemistry research services; biochemistry services; biological research; biotechnological research; biotechnology research; biotechnology testing; development of computer systems for the processing of data in the field of bioanalytics; development of chemical production testing methods for medical clinical trials; scientific research in the nature of conducting medical clinical trials for others; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research in the field of bioanalytics; medical research laboratory services; medical laboratory services being scientific research or analysis; laboratory testing services in the field of bioanalytics; pharmaceutical research services; preparation of reports relating to scientific research in the field of bioanalytics; provision of information relating to scientific research in the field of bioanalytics; pharmaceutical product quality testing; research laboratories in the field of bioanalytics; scientific research relating to data processing, namely, research on development of data processing programs by order of third parties; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of bioanalytics; scientific research consultancy in the field of bioanalytics; scientific laboratory services in the field of bioanalytics; scientific research in the field of bioanalytics; scientific testing services in the field of bioanalytics; services for assessing the safety of pharmaceuticals; testing of pharmaceutical products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgilex Biolabs Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameAgilex Biolabs Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameAgilex Biolabs Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Monday, March 6, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 10, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 10, 2023FINAL DISPOSITION PROCESSED
Wednesday, January 25, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Sunday, September 18, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, June 6, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Monday, May 9, 2022NOTIFICATION PROCESSED BY IB
Sunday, April 24, 2022REFUSAL PROCESSED BY IB
Wednesday, April 20, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 20, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 5, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, April 5, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 5, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, April 5, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 1, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 31, 2022REFUSAL PROCESSED BY MPU
Wednesday, March 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 30, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 4, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 3, 2022NON-FINAL ACTION WRITTEN
Thursday, March 3, 2022ASSIGNED TO EXAMINER
Tuesday, July 20, 2021APPLICATION FILING RECEIPT MAILED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB